Parmax Pharma Ltd - Stock Valuation and Financial Performance

BSE: 540359 | NSE: | Pharmaceuticals & Drugs | Small Cap

Parmax Pharma Share Price

43.70 -2.30 -5.00%
as on 20-Dec'24 16:59

DeciZen - make an informed investing decision on Parmax Pharma

M-Cap below 100cr DeciZen not available

Parmax Pharma stock performance -

mw4me loader
P/E Ratio (SA):
0.00
Market Cap:
16.4 Cr.
52-wk low:
24.2
52-wk high:
54

Is Parmax Pharma Ltd an attractive stock to invest in?

1. Is Parmax Pharma Ltd a good quality company?

Past 10 year’s financial track record analysis by Moneyworks4me indicates that Parmax Pharma Ltd is a below average quality company.

2. Is Parmax Pharma Ltd undervalued or overvalued?

The key valuation ratios of Parmax Pharma Ltd's currently when compared to its past seem to suggest it is in the Overvalued zone.

3. Is Parmax Pharma Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Parmax Pharma Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray of Parmax Pharma:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Parmax Pharma Ltd has not performed well majority of the past ten years indicating its past ten year financial track record is not good

Value Creation

Value Creation Index Colour Code Guide

Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24TTM
ROCE % 0.9%0.3%0.2%0.8%2%10.2%16.3%6.6%4%-59.9%-
Value Creation
Index
-0.9-1.0-1.0-0.9-0.9-0.30.2-0.5-0.7NA-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 00011.91220.926.218.215.41123
Sales YoY Gr.-NANANA0.9%74.3%25.1%-30.3%-15.6%-28.4%-
Adj EPS 0-0-000.20.81.50.3-0.2-11.3-9.1
YoY Gr.--125%NANANA460%76.2%-81.1%-171.4%NA-
BVPS (₹) 8.287.16.15.27.410.511.912.7-1.7-2.3
Adj Net
Profit
00000.10.40.80.1-0.1-5.8-3
Cash Flow from Ops. -0.10-0.53.90.92.83.50.80.3-0.2-
Debt/CF from Ops. -13.4-94.8-20.661.91.76.916.1-31.1-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales NA-1.7%-25.1%-28.4%
Adj EPS -287.3%-337.5%-297.1%NA
BVPS-184.1%-180.1%-154.6%-113.5%
Share Price - 19.4% -9.5% 38.8%

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24TTM
Return on
Equity %
0.6-0.1-0.201.78.913.92.4-1.8-195460.1
Op. Profit
Mgn %
0009.19.38.513.11414.7-30.6-5.5
Net Profit
Mgn %
00000.72.12.90.8-0.7-52.4-15
Debt to
Equity
0.20.10.30.72.11.51.31183.3-
Working Cap
Days
00018224113511013615421843
Cash Conv.
Cycle
000-60-185-83-72-81-355-29

Recent Performance Summary

Return on Equity has increased versus last 3 years average to 460.10%

Sales growth is good in last 4 quarters at 119.55%

Sales growth has been subdued in last 3 years -25.06%

Debt to equity has increased versus last 3 years average to 83.26

Latest Financials - Parmax Pharma Ltd.

Standalone Consolidated
TTM EPS (₹) -9.1 -
TTM Sales (₹ Cr.) 22.7 -
BVPS (₹.) -2.3 -
Reserves (₹ Cr.) -5 -
P/BV -19.40 -
PE 0.00 -
From the Market
52 Week Low / High (₹) 24.18 / 54.00
All Time Low / High (₹) 12.50 / 81.90
Market Cap (₹ Cr.) 16.4
Equity (₹ Cr.) 3.7
Face Value (₹) 10
Industry PE 44.3

Management X-Ray of Parmax Pharma:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Event Update

Login/Register to view analysis.

Analyst's Notes

Key Ratios of Parmax Pharma

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24
Sales00011.891220.9226.1818.2415.4011.02
Operating Expenses 0.020.050.0510.8010.8819.1522.7615.6813.1414.39
Manufacturing Costs0002.312.743.604.143.913.353.06
Material Costs0005.785.2011.2713.436.715.497.05
Employee Cost 0002.132.102.933.583.522.812.92
Other Costs 0.020.040.050.570.851.361.611.551.491.36
Operating Profit -0.02-0.05-0.051.081.111.773.422.562.26-3.37
Operating Profit Margin (%) ---9.1%9.3%8.5%13.0%14.0%14.7%-30.6%
Other Income 0.060.060.060.050.050.100.090.060.040.05
Interest 0000.040.030.130.360.390.370.62
Depreciation 0001.091.031.011.941.931.881.71
Exceptional Items 0000000000
Profit Before Tax 0.040.010.0100.100.731.210.300.05-5.66
Tax 0.010.020.0100.020.300.450.160.150.12
Profit After Tax 0.020-0.0100.080.430.750.14-0.10-5.78
PAT Margin (%) ---0.0%0.7%2.0%2.9%0.8%-0.7%-52.4%
Adjusted EPS (₹)0.10.00.00.00.21.22.00.4-0.3-15.5
Dividend Payout Ratio (%)0%0%0%0%0%0%0%0%0%0%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24

Equity and Liabilities

Shareholders Fund 4.154.564.564.564.645.065.825.965.860.07
Share Capital 4.034.454.454.454.454.454.454.454.454.45
Reserves 0.120.110.100.110.180.611.371.511.40-4.38
Minority Interest0000000000
Debt0.790.461.021.965.265.035.434.524.485.91
Long Term Debt0.790.461.021.965.265.035.434.524.485.91
Short Term Debt0000000000
Trade Payables0.010.012.099.659.199.629.925.524.667.39
Others Liabilities 0.030.040.040.440.551.341.561.972.611.96
Total Liabilities 4.975.087.7116.6019.6321.0622.7317.9717.6115.33

Fixed Assets

Gross Block2.532.532.736.967.049.6415.9217.4518.3819.87
Accumulated Depreciation0001.092.1205.0778.8810.60
Net Fixed Assets2.532.532.725.864.929.6410.8410.449.509.27
CWIP 00003.3300000.10
Investments 00000.200.200.20000
Inventories001.763.223.972.723.952.854.312.39
Trade Receivables0.080.090.121.971.153.301.650.680.621.82
Cash Equivalents 0.210.310.170.961.571.772.551.050.410.05
Others Assets2.142.142.934.594.503.433.532.952.781.69
Total Assets 4.975.087.7116.6019.6321.0622.7317.9717.6115.33

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24
Cash Flow From Operating Activity -0.060-0.503.880.922.823.530.750.33-0.19
PBT 0.040.010.0100.100.731.210.300.05-5.66
Adjustment -0.01-0.02-0.011.070.960.861.651.721.691.59
Changes in Working Capital -0.08-0-0.52.6-0.191.240.67-1.27-1.413.88
Tax Paid 0000.210.0600000
Cash Flow From Investing Activity 00-0.19-4.23-3.41-2.40-3.15-1.53-0.94-1.59
Capex 00-0.19-4.23-3.41-2.40-3.15-1.53-0.94-1.59
Net Investments 0000000000
Others 0000000000
Cash Flow From Financing Activity 00.100.561.143.10-0.230.40-0.91-0.041.43
Net Proceeds from Shares 0.130.4200000000
Net Proceeds from Borrowing -0.13-0.330.561.143.30-0.230.40-0.91-0.041.43
Interest Paid 0000000000
Dividend Paid 0000000000
Others 0000-0.2000000
Net Cash Flow -0.060.09-0.140.790.610.200.78-1.69-0.65-0.35
PARTICULARSMar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24
Ratios
ROE (%)0.7-0.12-0.280.023.7118.1922.553.38-2.26-281.14
ROCE (%)0.880.280.180.811.9610.1916.256.623.96-59.88
Asset Turnover Ratio0000.980.661.031.20.90.870.67
PAT to CFO Conversion(x)-3N/AN/AN/A11.56.564.715.36N/AN/A
Working Capital Days
Receivable Days00032473935231540
Inventory Days0007610958476885111
Payable Days000371661305265420338312

Parmax Pharma Ltd Stock News

Parmax Pharma Ltd FAQs

Company share prices are keep on changing according to the market conditions. The closing price of Parmax Pharma on 20-Dec-2024 16:59 is ₹43.70.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 20-Dec-2024 16:59 the market cap of Parmax Pharma stood at ₹16.35.
The latest P/E ratio of Parmax Pharma as of 20-Dec-2024 16:59 is 0.00.
The latest P/B ratio of Parmax Pharma as of 20-Dec-2024 16:59 is -19.40.
The 52-week high of Parmax Pharma is ₹54.00 and the 52-week low is ₹24.18.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Parmax Pharma is ₹22.68 ( Cr.) .

About Parmax Pharma Ltd

No data to display
You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.